Relmada Therapeutics
Price & Volume
Stats
See more52W Range | $0.24-$3.98 |
Market Cap | $55M |
Shares Short | 711,326 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.20 |
News
See moreYahoo Finance • 12 days ago
Relmada regains Nasdaq compliance on minimum bid price
Yahoo Finance • 18 days ago
Relmada Issues Mid-Year CEO Letter to Shareholders
Yahoo Finance • 25 days ago
On Wednesday, there are stocks with unusual volume. Let's take a look.
Yahoo Finance • 2 months ago
Relmada outlines 2026 trial launches for NDV-01 and sepranolone as pipeline advances
About
CEO | Dr. Sergio Traversa M.B.A., Pharm.D. |
Address | 2222 Ponce de Leon Blvd., Coral Gables, FL, United States, 33134 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 17 |
